Page last updated: 2024-10-21

monomethylpropion and Parkinson Disease, Secondary

monomethylpropion has been researched along with Parkinson Disease, Secondary in 9 studies

monomethylpropion: metabolite of dimethylpropion; structure given in first source
2-methylamino-1-phenylpropan-1-one : An aromatic ketone that is propiophenone in which the hydrogen alpha- to the keto group has been replaced by a methylamino group.
methcathinone : A racemate comprising equal amounts of (R)- and (S)-methcathinone.

Parkinson Disease, Secondary: Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42)

Research Excerpts

ExcerptRelevanceReference
"Ephedrone patients and patients with opioid dependence were recruited from Lviv, Ukraine."1.39Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism. ( Averbeck, BB; Bearn, J; Djamshidian, A; Fedoryshyn, L; Filts, Y; Lees, AJ; Matviyenko, Y; O'Sullivan, SS; Sanotsky, Y; Selikhova, M; Sharman, S, 2013)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's2 (22.22)29.6817
2010's6 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chong, TT1
Bonnelle, V1
Veromann, KR1
Juurmaa, J1
Taba, P3
Plant, O1
Husain, M1
Sikk, K2
Selikhova, M2
Tripoliti, E1
Fedoryshyn, L2
Matvienko, Y1
Stanetska, H1
Boychuk, M1
Komnatska, I1
Lees, AJ2
Sanotsky, Y2
Colosimo, C1
Guidi, M1
Stepens, A2
Stagg, CJ1
Platkajis, A2
Boudrias, MH1
Johansen-Berg, H1
Donaghy, M2
Djamshidian, A1
Matviyenko, Y1
O'Sullivan, SS1
Sharman, S1
Filts, Y1
Bearn, J1
Averbeck, BB1
Haldre, S1
Aquilonius, SM1
Asser, A1
Paris, M1
Roose, Ä1
Petterson, J1
Eriksson, SL1
Bergquist, J1
Logina, I1
Liguts, V1
Aldins, P1
Eksteina, I1
Mārtinsone, I1
Tērauds, E1
Rozentāle, B1
McCann, UD1
Wong, DF1
Yokoi, F1
Villemagne, V1
Dannals, RF1
Ricaurte, GA1

Reviews

1 review available for monomethylpropion and Parkinson Disease, Secondary

ArticleYear
Methcathinone "Kitchen Chemistry" and Permanent Neurological Damage.
    International review of neurobiology, 2015, Volume: 120

    Topics: Brain; Humans; Manganese; Neuroimaging; Parkinson Disease, Secondary; Propiophenones

2015

Other Studies

8 other studies available for monomethylpropion and Parkinson Disease, Secondary

ArticleYear
Dissociation of reward and effort sensitivity in methcathinone-induced Parkinsonism.
    Journal of neuropsychology, 2018, Volume: 12, Issue:2

    Topics: Adult; Brain; Case-Control Studies; Decision Making; Female; Humans; Male; Manganese Poisoning; Moti

2018
Analysis of a distinct speech disorder seen in chronic manganese toxicity following Ephedrone abuse.
    Clinical neurology and neurosurgery, 2016, Volume: 147

    Topics: Adult; Dysarthria; Globus Pallidus; Humans; Male; Manganese Poisoning; Neostriatum; Parkinson Diseas

2016
Parkinsonism due to ephedrone neurotoxicity: a case report.
    European journal of neurology, 2009, Volume: 16, Issue:6

    Topics: Adult; Antiparkinson Agents; Corpus Striatum; Europe, Eastern; Gait Disorders, Neurologic; Humans; I

2009
White matter abnormalities in methcathinone abusers with an extrapyramidal syndrome.
    Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 12

    Topics: Adult; Basal Ganglia Diseases; Brain; Data Interpretation, Statistical; Diffusion Magnetic Resonance

2010
Increased reflection impulsivity in patients with ephedrone-induced Parkinsonism.
    Addiction (Abingdon, England), 2013, Volume: 108, Issue:4

    Topics: Adult; Amphetamine-Related Disorders; Case-Control Studies; Decision Making; Drug Contamination; Fee

2013
Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-up.
    European journal of neurology, 2013, Volume: 20, Issue:6

    Topics: Adolescent; Adult; Biomarkers; Cohort Studies; Estonia; Female; Follow-Up Studies; Hair; Humans; Mal

2013
A Parkinsonian syndrome in methcathinone users and the role of manganese.
    The New England journal of medicine, 2008, Mar-06, Volume: 358, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Age of Onset; Drug Contamination; Female; Globus Pallidus

2008
Reduced striatal dopamine transporter density in abstinent methamphetamine and methcathinone users: evidence from positron emission tomography studies with [11C]WIN-35,428.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 1998, Oct-15, Volume: 18, Issue:20

    Topics: Adult; Amphetamine-Related Disorders; Brain Chemistry; Carbon Radioisotopes; Carrier Proteins; Centr

1998